Resmed Inc
XMUN:RME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Resmed Inc
XMUN:RME
|
US |
|
Y
|
Yum! Brands Inc
XMUN:TGR
|
US |
|
BayWa AG
F:BYW
|
DE |
|
L
|
Lenzing AG
VSE:LNZ
|
AT |
|
O
|
Onto Innovation Inc
SWB:NNM
|
US |
|
Sama Resources Inc
XTSX:SME
|
CA |
Wall St Price Targets
RME Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for RME is 238.8 EUR with a low forecast of 163.3 EUR and a high forecast of 306.53 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RME's stock price target?
Price Target
238.8
EUR
According to Wall Street analysts, the average 1-year price target for RME is 238.8 EUR with a low forecast of 163.3 EUR and a high forecast of 306.53 EUR.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 4 years is 8%.
What is the Gross Profit forecast for Resmed Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 4 years is 10%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 4 years is 12%.
What is the Pre-Tax Income forecast for Resmed Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 4 years is 11%.
